×
Oramed Pharmaceuticals EBIT 2011-2024 | ORMP
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Oramed Pharmaceuticals ebit from 2011 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Oramed Pharmaceuticals EBIT 2011-2024 | ORMP
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Oramed Pharmaceuticals ebit from 2011 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$204.2B
Stryker (SYK)
$146.7B
Boston Scientific (BSX)
$132.6B
EssilorLuxottica (ESLOY)
$112.1B
Medtronic (MDT)
$110.6B
Haleon (HLN)
$43.7B
Lonza Group Ag (LZAGY)
$42.2B
GE HealthCare Technologies (GEHC)
$37.7B
ResMed (RMD)
$35.8B
Terumo (TRUMY)
$29.7B
Koninklijke Philips (PHG)
$24.8B
Zimmer Biomet Holdings (ZBH)
$21.9B
Insulet (PODD)
$18.4B
Baxter (BAX)
$17B
Smith & Nephew SNATS (SNN)
$11.1B
BellRing Brands (BRBR)
$10.2B
Bio-Rad Laboratories (BIO)
$9.3B
Demant (WILYY)
$8.3B
Lantheus Holdings (LNTH)
$6.3B
TG Therapeutics (TGTX)
$5.5B
Haemonetics (HAE)
$4.3B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4.1B
Perrigo (PRGO)
$3.8B
Envista Holdings (NVST)
$3.7B
Neogen (NEOG)
$3.2B
Agios Pharmaceuticals (AGIO)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.8B
QuidelOrtho (QDEL)
$2.7B